AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Penumbra (PEN) Receives Buy Rating from RBC Capital with $325 Price Target
ByAinvest
Wednesday, Aug 13, 2025 6:46 pm ET1min read
RBC Capital maintains a Buy rating for Penumbra with a price target of $325. Analyst Singh Chadha has a 48.51% success rate and covers healthcare stocks like Medtronic and Globus Medical. Penumbra's latest earnings report showed a quarterly revenue of $339.46 million and a net profit of $45.27 million.
RBC Capital has maintained its Buy rating for Penumbra (NYSE:PEN), with a price target of $325. This rating comes from analyst Singh Chadha, who has a 48.51% success rate and covers healthcare stocks such as Medtronic and Globus Medical. Chadha's optimism is supported by Penumbra's latest earnings report, which showed a quarterly revenue of $339.46 million and a net profit of $45.27 million [2].The latest earnings report highlights Penumbra's strong performance in the healthcare sector. The company's revenue grew by 13.4% compared to the same quarter last year, with a net profit margin of 11.54%. The company's earnings per share (EPS) for the quarter was $0.86, beating the consensus estimate of $0.81 by $0.05 [2].
Chadha's positive outlook is further backed by the company's strong cash flow growth, which has been 8.3% year-over-year, outperforming the industry average of 2.9% [1]. Additionally, the company's historical cash flow growth rate over the past 3-5 years has been 21.3%, compared to the industry average of 9% [1].
The company's earnings estimate revisions have also been positive, with a 0.9% upward revision in the current-year earnings estimate over the past month [1]. This trend suggests that analysts are increasingly optimistic about Penumbra's future prospects.
Penumbra's strong performance and positive analyst sentiment make it an attractive investment opportunity. However, investors should always conduct their own research and consider their risk tolerance before making any investment decisions.
References:
[1] https://www.nasdaq.com/articles/rbc-bearings-rbc-solid-growth-stock-3-reasons-think-yes
[2] https://www.marketbeat.com/instant-alerts/filing-informed-momentum-co-llc-makes-new-399-million-investment-in-penumbra-inc-nysepen-2025-08-12/
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet